Victoria Chapman Selected Research

Gliosis

4/2024	Sustained morphine exposure alters spinal NMDA receptor and astrocyte expression and exacerbates chronic pain behavior in female rats.
1/2017	Targeting the D Series Resolvin Receptor System for the Treatment of Osteoarthritis Pain.
1/2013	Cannabinoid CB2 receptors regulate central sensitization and pain responses associated with osteoarthritis of the knee joint.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Victoria Chapman Research Topics

Disease

51	Pain (Aches) 04/2024 - 02/2002
20	Osteoarthritis 04/2024 - 01/2008
16	Inflammation (Inflammations) 11/2022 - 05/2002
13	Chronic Pain 04/2024 - 08/2007
11	Neuralgia (Stump Neuralgia) 10/2020 - 02/2002
10	Hyperalgesia 01/2018 - 12/2005
6	Hypersensitivity (Allergy) 11/2021 - 12/2005
5	Knee Osteoarthritis 01/2022 - 09/2011
4	Arthralgia (Joint Pain) 04/2024 - 11/2011
4	Synovitis 11/2022 - 09/2014
3	Gliosis 04/2024 - 01/2013
2	Osteophyte 11/2018 - 08/2014
1	Knee Injuries (Knee Injury) 02/2024
1	Neurogenic Inflammation 10/2022
1	Migraine Disorders (Migraine) 10/2022
1	COVID-19 01/2022
1	Long Term Adverse Effects 01/2022
1	Cognitive Dysfunction 09/2017

Drug/Important Bio-Agent (IBA)

22	Analgesics (Analgesic Drugs)IBA 01/2022 - 12/2006
15	EndocannabinoidsIBA 11/2017 - 12/2006
13	Iodoacetic AcidIBA 04/2024 - 11/2011
12	CannabinoidsIBA 09/2017 - 02/2002
10	CarrageenanIBA 11/2020 - 08/2003
6	LipidsIBA 02/2024 - 04/2013
5	fatty-acid amide hydrolase (fatty acid amide hydrolase)IBA 10/2012 - 12/2006
4	anandamide (arachidonylethanolamide)IBA 04/2024 - 07/2008
4	Opioid Analgesics (Opioids)IBA 04/2024 - 11/2021
4	CB2 Cannabinoid ReceptorIBA 01/2013 - 11/2004
3	14,15-dihydroxyeicosatrienoic acidIBA 04/2024 - 01/2022
3	AcidsIBA 04/2024 - 09/2014
3	OxylipinsIBA 04/2024 - 01/2018
3	salicylhydroxamic acid (SHAM)IBA 11/2022 - 11/2004
3	Nerve Growth Factor (NGF)IBA 10/2022 - 09/2014
3	CollagenIBA 01/2021 - 06/2015
3	TropomyosinIBA 01/2020 - 09/2014
3	Phosphotransferases (Kinase)IBA 01/2020 - 09/2014
3	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 01/2016 - 08/2003
3	1,1-dimethylbutyl-1-deoxy-Delta(9)-THCIBA 01/2013 - 11/2004
3	Cannabinoid Receptors (Cannabinoid Receptor)IBA 10/2012 - 01/2008
3	cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester (URB597)IBA 10/2012 - 07/2008
3	Cannabinoid Receptor AgonistsIBA 12/2005 - 02/2002
2	Glial Fibrillary Acidic ProteinIBA 04/2024 - 03/2019
2	Pain-FreeIBA 04/2024 - 03/2019
2	Morphine (MS Contin)FDA LinkGeneric 04/2024 - 11/2021
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 10/2022 - 01/2020
2	Epoxide HydrolasesIBA 01/2022 - 01/2018
2	LigandsIBA 11/2021 - 04/2013
2	Calcitonin Gene-Related PeptideIBA 11/2020 - 06/2015
2	Messenger RNA (mRNA)IBA 10/2020 - 01/2013
2	Transient Receptor Potential ChannelsIBA 01/2017 - 09/2011
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2017 - 07/2008
2	MJN110IBA 11/2016 - 09/2013
2	Capsaicin (Zostrix)FDA Link 01/2016 - 12/2006
2	Diphosphonates (Bisphosphonates)IBA 08/2014 - 01/2011
2	EnzymesIBA 09/2013 - 12/2012
2	CytokinesIBA 01/2013 - 09/2011
2	nimesulide (Aulin)IBA 11/2011 - 07/2008
2	Minocycline (Cyclops)FDA LinkGeneric 11/2011 - 07/2009
1	8,9-epoxyeicosatrienoic acidIBA 04/2024
1	Arachidonic Acid (Vitamin F)IBA 04/2024
1	5-hydroxy-6,8,11,14-eicosatetraenoic acidIBA 04/2024
1	Hydroxyeicosatetraenoic Acids (HETE)IBA 04/2024
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 04/2024
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 02/2024
1	CannabidiolIBA 01/2023
1	Inflammation MediatorsIBA 11/2022
1	Substance PIBA 10/2022
1	EndorphinsIBA 11/2021
1	Naloxone (Narcan)FDA LinkGeneric 11/2021
1	Serine (L-Serine)FDA Link 11/2021
1	Pyruvic Acid (Pyruvate)IBA 01/2021
1	Amino Acids FDA Link 01/2021
1	Freund's AdjuvantIBA 11/2020
1	LectinsIBA 11/2020
1	Glutamate Receptors (Glutamate Receptor)IBA 11/2019
1	PropionatesIBA 11/2019
1	CalciumIBA 11/2019
1	alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA 11/2019
1	AMPA Receptors (AMPA Receptor)IBA 11/2019
1	2'-deoxyadenosineIBA 01/2019
1	cordycepinIBA 01/2019
1	mRNA Cleavage and Polyadenylation FactorsIBA 01/2019
1	CRA 013783IBA 11/2018
1	Cathepsin KIBA 11/2018
1	Ala(2)-MePhe(4)-Gly(5)- Enkephalin (DAGO)IBA 01/2018
1	mu Opioid Receptors (mu Opioid Receptor)IBA 01/2018
1	Opioid Peptides (Opioid Peptide)IBA 11/2017
1	Therapeutic UsesIBA 01/2017
1	resolvin D2IBA 01/2017
1	17- hydroxy- 4,7,10,13,15,19- docosahexaenoic acidIBA 01/2017
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2017
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017
1	Triamcinolone Acetonide (Azmacort)FDA LinkGeneric 01/2017
1	Lipase (Acid Lipase)FDA Link 11/2016
1	MonoglyceridesIBA 11/2016

Therapy/Procedure

8	Intra-Articular Injections 04/2024 - 12/2010
4	Therapeutics 01/2022 - 09/2014
4	Analgesia 11/2021 - 01/2008
2	Ligation 07/2009 - 12/2006
1	Drug Therapy (Chemotherapy) 10/2020